Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02811705
NCT02811705
Completed
Not Applicable

Life Quality Study for PFAPA Patient

Versailles Hospital2 sites in 1 country60 target enrollmentJuly 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPFAPA Syndrome

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PFAPA Syndrome
Sponsor
Versailles Hospital
Enrollment
60
Locations
2
Primary Endpoint
Compare quality of life from patients with PFAPA and FMF, reported by parents and by patients themselves
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This cohort study aims to assess the quality of life (or welfare) related to the health of children and adolescents with an non genetics auto-inflammatory disease PFAPA or Marshall syndrome to compare it to children or adolescents with recurrent fever genetics of Familial Mediterranean fever (FMF) in order to improve their overall care.

Registry
clinicaltrials.gov
Start Date
July 2015
End Date
April 2017
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Versailles Hospital
Responsible Party
Principal Investigator
Principal Investigator

Véronique Hentgen

Dr

Versailles Hospital

Eligibility Criteria

Inclusion Criteria

  • •PFAPA syndrome patients or FMF patients

Exclusion Criteria

  • •Participation refusal

Outcomes

Primary Outcomes

Compare quality of life from patients with PFAPA and FMF, reported by parents and by patients themselves

Time Frame: 1 day

Secondary Outcomes

  • Evaluate the fatigue status of patients through questionnaire PedsQL TM 3.0 multidimensional scale tiredness(1 day)

Study Sites (2)

Loading locations...

Similar Trials

Completed
Not Applicable
Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With CisplatinPeritoneal Neoplasms
NCT00502177M.D. Anderson Cancer Center48
Withdrawn
Not Applicable
Quality of Life and Psycological Evaluation of Patients Affected by Head and Neck CancerQuality of Life
NCT02984033Michele Tedeschi
Recruiting
Not Applicable
Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025Radiation ToxicityChemotherapeutic ToxicityChemotherapy-induced Peripheral NeuropathyDelayed Wound HealingChronic PainRefractory Pain
NCT05417737Bernardino Clavo, MD, PhD105
Not yet recruiting
Not Applicable
Longitudinal Study on the QoL of Pediatric Patients After HSCT and Its Influencing FactorsThalassemia MajorAcute Leukemia
NCT06026839Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University250
Completed
Not Applicable
A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg TabletsRheumatic Diseases
NCT00642837Janssen Korea, Ltd., Korea982